Recent Articles by Maxx Chatsko
By Maxx Chatsko | June 22, 2018 |
The fast pace of innovation in biotech is the biggest risk to Illumina's future. With a $42 billion market cap, it could sting sooner than investors think.
By Maxx Chatsko | June 18, 2018 |
Both shipping stocks have been on fire since early April 2018. Is this the sign investors have been waiting for?
By Maxx Chatsko | May 29, 2018 |
The field of synthetic biology has not been good to investors. But maybe we've just been looking in the wrong places.
By Maxx Chatsko | January 17, 2018 |
Most of the hype centers on passenger vehicles and tractor trailers, but autonomous vehicles could revolutionize mining.
By Maxx Chatsko | December 15, 2017 |
The fourth quarter of every year is usually the strongest for ethanol producers. But there's another major catalyst (and several smaller ones) this year.
By Maxx Chatsko | October 06, 2017 |
Investors are still waiting for next-generation biotech to deliver on its enormous promise and potential, but just one of these Holy Grails would make the wait worth it.
By Maxx Chatsko | August 21, 2017 |
Investors looking for cheap income stocks should take a closer look at General Motors, Total SA, and U.S. Silica Holdings.
By Maxx Chatsko | June 19, 2017 |
If billionaires own Intrexon, CVR Energy, and Kinder Morgan, then does that mean you should give these stocks a closer look for your portfolio?